This minimum list includes genes associated with a phenotype, such as hereditary breast or ovarian cancer (BRCA1 and 2), Li–Fraumeni syndrome (TP53), or Lynch syndrome (MLH1, MSH2, MSH6, PMS2), besides others [24, 25]. This evidence concerns the gene PMS2 and ovarian cancer.